Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapy

Journal of the American Society of Nephrology

Volumn 8, Issue 1, 1997, Pages 118-125

  Brennan, Daniel C ^a,c   Garlock, Kathy A ^b   Lippmann, Bruce A ^a   Buller, Richard S ^a   Gaudreault Keener, Monique ^a   Lowell, Jeffrey A ^a   Miller, Steven B ^a   Shenoy, Surendra ^a   Howard, Todd K ^a   Storch, Gregory A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

^c Campus Box 8126   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CYCLOSPORIN; GANCICLOVIR; PREDNISONE; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT REJECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; MONITORING; MORBIDITY; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0030725003     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v81118     Document Type: Article

References (45)

1. Ho M: Cytomegalovirus infection and indirect sequelae in the immunocompromised transplant patient. Transplant Proc 23: 2-7, 1991
2. Nevins TE, Dunn DL: Use of ganciclovir for cytomegalovirus infection. J Am Soc Nephrol 2: S270-S273, 1992
3. Farrugia E, Schwab TR: Management and prevention of cytomegalovirus infection after renal transplantation. Mayo Clin Proc 67: 879-890, 1992
4. Hibberd PL, Tolkoff-Rubin NE, Cosimi A B, Schooley RT, Isaacson D, Doran M, Delvecchio A, Delmonico FL, Auchincloss H Jr, Rubin RH: Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation 53: 68-72, 1992
5. Tsevat J, Snydman DR, Pauker SG, Durand-Zaleski I, Werner BG, Levey AS: Which renal transplant patients should receive cytomegalovirus immune globulin? Transplantation 52: 259-265, 1991
6. McCarthy JM, Karim MA, Krueger H, Keown PA: The cost impact of cytomegalovirus disease in renal transplant recipients. Transplantation 55: 1277-1282, 1993
7. Davis CL: The prevention of cytomegalovirus disease in renal transplantation. Am J Kidney Dis 16: 175-188, 1990
8. Rubin RH: Infectious disease complications of renal transplantation. Kidney Int 44: 221-236, 1993
9. Mills J, Jacobson MA, O'Donnell JJ, Cederberg D, Holland GN: Treatment of cytomegalovirus retinitis in patients with AIDS. Rev Infect Dis 3: S522-S531, 1988
10. Snydman DR: Ganciclovir therapy for cytomegalovirus disease associated with renal transplants. Rev Infect Dis 10: S554-S562, 1988
11. Balfour HH, Chace BA, Stapleton JT, Simmons RL, Fryd DS: A randomized placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med 320: 1381-1387, 1989
12. Bailey TC, Ettinger NA, Storch GA, Trulock EP, Hanto DW, Dunagan WC, Jendrisak MD, McCullough CS, Kenzora JL, Powderly WG: Failure of high-dose acyclovir with or without immune globulin to prevent primary cytomegalovirus disease in recipients of solid organ transplants. Am J Med 95: 273-278, 1993
13. Merigan TC, Renlund DG, Keay S, Bristow MR, Starnes V, O'Connell JB, Resta S, Dunn D, Gamberg P, Ratkovec RM, Richenbacher WE, Millar RC, Dumond C, DeAmond B, Sullivan V, Cheney T, Buhles W, Stinson EB: A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med 326: 1182-1186, 1992
14. Goodrich JM, Mori M, Gleaves CA: Du Mond C, Cays M, Ebeling DF, Buhles WC, DeArmond B, Meyers JD: Early treatment of ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med 325: 1601-1606, 1991
15. Schmidt GM, Horak DA, Niland JC, Duncan SR, Forman SJ, Zaia JA, City of Hope-Stanford-Syntex CMV Study Group: A randomized controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. N Engl J Med 324: 1005-1011, 1991
16. Bailey TC, Trulock EP, Ettinger NA, Storch G, Cooper J, Powderly WG: Failure of prophylactic ganciclovir to present cytomegalovirus disease in lung transplant recipients. J Infect Dis 165: 548-552, 1992
17. Hibberd PL, Tolkoff-Rubin NE, Conti D, Stuart F, Thistlewaite JR, Neylan JF, Snydman DR, Freeman R, Lorber MI, Rubin RH: Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. Ann Intern Med 123: 18-26, 1995
18. Snydman DR, Werner BG, Heinze-Lacey B, Berardi VP, Tilney NL, Kirkman RL, Milford EL, Cho SI, Bush HL Jr, Levey AS: Use of cytomegalovirus immune-globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med 317: 1049-1054, 1987
19. Snydman DR, Werner BG, Tilney NL, Kirkman RL, Milford EL, Cho SI, Bush HL Jr, Levey AS, Strom TB, Carpenter CB: Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: Comparison of the randomized and open-label trials. Transplant Proc 23: 1357-1360, 1991
20. McCune TR, Johnson HK, MacDonell RC, Richie RE, Nylander WA, Van Buren DH, Helderman JH: The effect of polyimmune gammaglobulin for prophylaxis against reactivation cytomegalovirus infection in kidney and kidney-pancreas transplant recipients. J Am Soc Nephrol 2: 1469-1474, 1992
21. Conti DJ, Freed BM, Gruber SA, Lempert N: Prophylaxis of primary cytomegalovirus disease in renal transplant recipients. Arch Surg 129: 442-447, 1994
22. Steinmuller DR, Novick AC, Streem SB, Graneto D, Swift C: Intravenous immunoglobulin infusions for the prophylaxis of secondary cytomegalovirus infection. Transplantation 49: 68-70, 1990
23. Glowacki LS, Smaill F: Use of immunoglobulin to prevent cytomegalovirus infections in transplantation a meta-analysis. Clin Transplant 8: 1-8, 1994
24. Glenn J: Cytomegalovirus infections following renal transplantation. Rev Infect Dis 3: 1151-1178, 1981
25. Marsano L, Perrillo RP, Flye MW, Hanto DW, Spitzer ED, Thomas JR, Murray PR, Windus DW, Brunt EM, Storch GA: Comparison of culture and serology for the diagnosis of cytomegalovirus infection in kidney and liver transplant recipients. J Infect Dis 161: 454-461, 1990
26. Storch GA, Buller RS, Bailey TC, Ettinger NA, Langlois T, Gaudreault-Keener M, Welby PL: Comparison of PCR and pp65 antigenemia assay with quantitative shell vial culture for detection of cytomegalovirus in blood leukocytes from solid-organ transplant recipients. J Clin Micro 32: 997-1003, 1994
27. Richardson WP, Colvin RB, Cheeseman SH, Tolkoff-Rubin NE, Herrin JT, Cosimi AB: Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med 305: 257-263, 1981
28. Thiele GM, Bicak MS, Young A, Kinsey J, White RJ, Purtilo DT: Rapid detection of cytomegalovirus by tissue culture centrifugation and immunofluorescence with a monoclonal antibody to an early nuclear antigen. J Virol Meth 16: 327-338, 1987
29. Buller RS, Bailey TC, Ettinger NA, Keener M, Langlois T, Miller JP, Storch GA: Use of a modified shell-vial technique to quantitate CMV viremia in a population of solid-organ transplant recipients. J Clin Micro 10: 2620-2624, 1992
30. Drew WL: Diagnosis of cytomegalovirus infection. Rev Infect Dis 10: S468-S476, 1988
31. Jiwa NM, Van Gemert GW, Raap AK, Van De Rijke FM, Mulder A, Lens PF, Salimans MM, Zwaan FE, Van Dorp W, Van der Ploeg M: Rapid detection of human cytomegalovirus DNA in peripheral blood leukocytes of viremic transplant recipients by the polymerase chain reaction. Transplantation 48: 72-76, 1989
32. The TH, van der Ploeg M, van den Berg AP, Vlieger AM, van der Giessen M, van Son WJ: Direct detection of cytomegalovirus in peripheral blood leukocytes: A review of the antigenemia assay and polymerase chain reaction. Transplantation 54: 193-198, 1992
33. Rowley AH, Wolinsky SM, Sambol SP, Barkholt L, Ehrnst A, Andersson JP: Rapid detection of cytomegalovirus DNA and RNA in blood of renal transplant patients by in vitro enzymatic amplification. Transplantation 51: 1028-1033, 1991
34. Shibata DWJ, Martin MD, Appleman DM, Causey JM, Leedom and Arnheim N: Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus. J Infect Dis 158: 1185-1192, 1988
35. Spector SA, Merrill R, Wolf D, Danker WM: Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification. J Clinical Micro 30: 2359-2365, 1992
36. Chen YT, Mercer GO, Cheigh JS, Mouradian JA: Cytomegalovirus infection of renal allografts. Transplantation 53: 99-102, 1992
37. Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, Croker BP, Droz D, Dunnill MS, Halloran PF: International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 44: 411-422, 1993
38. Crumpacker CS: Ganciclovir. N Engl J Med 335: 721-728, 1996
39. Kletzmayr J, Kotzmann H, Kovarik J, Klauser R, Popow-Kraupp T: Impact of high-dose oral acyclovir prophylaxis on cytomegalovirus (CMV) disease in CMV high-risk renal transplant recipients. J Am Soc Nephrol 7: 325-330, 1996
40. Brennan DC, Storch GA, Lippman BJ: Preemptive ganciclovir therapy in renal transplantation [Letter]. Ann Intern Med 124: 693, 1996
41. Rossi SJ, Schroeder TJ, Muth KL, Hanto DW, Balistreri WF, Ryckman FC: Soluble interleukin-2 receptor monitoring during bacterial and viral infections in liver transplant recipients: A comparative evaluation. Clin Transplant 8: 479-484, 1994
42. Einsele H, Ehninger G, Steidle M, Vallbracht A, Muller M, Schmidt H, Saal JG, Waller HD, Muller CA: Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus diseases. Lancet 338: 1170-1172, 1991
43. Bitsch A, Kirchner H, Dennin R, Hoyer J, Fricke L, Steinhoff J, Sack K, Bein G: The long persistence of CMV DNA in the blood of renal transplant patients after recovery from CMV infection. Transplantation 56: 108-113, 1993
44. Fox JC, Kidd M, Griffiths PC, Sweny P, Emery: Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: Correlation with disease. J Gen Virol 76: 309-319, 1995
45. Landry ML, Ferguson D, Cohen S, Huber K, Wetherill P: Effect of delayed specimen processing on cytomegalovirus antigenemia test results. J Clin Microbiol 33: 257-259, 1995